Optibrium Ltd News Today

Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, optimisation, and data analysis.

New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound

The study suggests that Optibrium’s augmented chemistry can replace the need for human clinical trials when developing new flavor and fragrance ingredients.

Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi that endangers almost 70 million people worldwide. The only two drugs that are currently approved for its treatment, benznidazole and nifurtimox, have controversial efficacy in adults and restricting safety issues, leaving thousands of patients without a suitable treatment. The neglect of Chagas disease is further illustrated by the lack of a robust and diverse drug discovery and development portfol...

The recent report on “Global Molecular Modelling Market Report by Key Players, Types, Applications, Market Size, Market Share, Regions and  Forecast to 2027” offered by Data bridge market research covers various industry dynamics and tendencies that helps in the market growth.Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Molecular Modelling Market”. The research report also offers the lates...

25 The recent report on “Global Molecular Modelling Market Report by Key Players, Types, Applications, Market Size, Market Share, Regions and  Forecast to 2027” offered by Data bridge market research covers various industry dynamics and tendencies that helps in the market growth.Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Molecular Modelling Market”. The research report also offers the l...